Editorial
doi: 10.1161/CIRCINTERVENTIONS.109.921577.
Clopidogrel for the hot patient
- PMID: 20031764
- PMCID: PMC4086861
- DOI: 10.1161/CIRCINTERVENTIONS.109.921577
Item in Clipboard
Editorial
Clopidogrel for the hot patient
Circ Cardiovasc Interv.
2009 Dec.
No abstract available
Comment on
-
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.Circ Cardiovasc Interv. 2009 Dec;2(6):503-12. doi: 10.1161/CIRCINTERVENTIONS.109.879312. Epub 2009 Nov 17. Circ Cardiovasc Interv. 2009. PMID: 20031767
Similar articles
-
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.Circ Cardiovasc Interv. 2009 Dec;2(6):503-12. doi: 10.1161/CIRCINTERVENTIONS.109.879312. Epub 2009 Nov 17. Circ Cardiovasc Interv. 2009. PMID: 20031767
-
Stent thrombosis after drug eluting stent implantation.Circ J. 2011;75(6):1316-7. doi: 10.1253/circj.cj-11-0407. Epub 2011 Apr 29. Circ J. 2011. PMID: 21532176 No abstract available.
-
Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6. Am J Cardiol. 2001. PMID: 11564394 No abstract available.
-
Clinical update on the therapeutic use of clopidogrel: treatment of acute ST-segment elevation myocardial infarction (STEMI).Vasc Health Risk Manag. 2006;2(4):379-87. doi: 10.2147/vhrm.2006.2.4.379. Vasc Health Risk Manag. 2006. PMID: 17323592 Free PMC article. Review.
-
Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):79S-88S. doi: 10.1016/s0735-1097(02)02831-0. J Am Coll Cardiol. 2003. PMID: 12644345 Review.
Cited by
-
Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?Curr Rheumatol Rep. 2014 Feb;16(2):403. doi: 10.1007/s11926-013-0403-6. Curr Rheumatol Rep. 2014. PMID: 24390757 Review.
References
-
- Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874. - PubMed
-
- Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol. 2009;54:669–677. - PubMed
-
- Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA. 1997;94:1931–1936. - PMC - PubMed
-
- Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591–594. - PubMed
-
- Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998;394:200–203. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
